共 50 条
- [43] Potential eligibility of congenital heart disease patients for subcutaneous implantable cardioverter-defibrillator based on surface electrocardiogram mapping EUROPACE, 2015, 17 (07): : 1059 - 1067
- [45] Lesion-Specific Differences for Implantable Cardioverter Defibrillator Therapies in Adults with Congenital Heart Disease PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2014, 37 (11): : 1492 - 1498
- [46] Totally Subcutaneous Implantable Cardioverter-defibrillator in a Child With Complex Congenital Heart Disease and Infection in a Previous Transvenous System REVISTA ESPANOLA DE CARDIOLOGIA, 2014, 67 (11): : 961 - 962
- [48] PREVENTION-ACHD: PRospEctiVE study on implaNTable cardioverter-defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease; Rationale and Design Netherlands Heart Journal, 2019, 27 : 474 - 479
- [50] The validity of current implantable cardioverter-defibrillator guidelines in a real-world population of adults with congenital heart disease: A single-center experience INTERNATIONAL JOURNAL OF CARDIOLOGY CONGENITAL HEART DISEASE, 2022, 8